The interactions between hydrogen, sEH regulation, Aβ dynamics, and gut microbiota offer exciting avenues for future research, with the potential to uncover novel therapeutic strategies for AD and other neurodegenerative diseases. This evidence concerns the gene EPHX2 and Alzheimer disease.